John Young is an accomplished board member with extensive experience in the pharmaceutical and healthcare industries. Currently serving as a board member for Novartis since March 2023, Arvinas since August 2022, and Johnson Controls since December 2017, Young has a strong focus on advancing health and technology. Previous board membership includes Imbria Pharmaceuticals from March 2022 to July 2024 and Haleon from July 2022 to March 2023. Notably, Young held a long tenure at Pfizer from September 1987 to July 2022, culminating in roles such as Special Advisor to the CEO and Group President. Educational credentials include a B.Sc in Biology from the University of Glasgow and an MBA from the University of Strathclyde.
This person is not in the org chart
This person is not in any teams
This person is not in any offices